18Sep
Government Continues to Closely Scrutinize Pharmaceutical Marketing Practices
On September 4, 2019 the Department of Justice (DOJ) announced a $15.4 million settlement with pharmaceutical company Mallinckrodt ARD LLC (Mallinckrodt) to resolve alleged violations of the Anti-Kickback Statute (AKS) in two whistleblower suits...
By:
Robinson+Cole Health Law Diagnosis
Related
The burgeoning gig economy helps companies attract talent and gain new levels of nimbleness in suppo...
Read More >
Background - On January 13, 2020, the U.S. Department of Treasury, on behalf of the Committee on Fo...
Read More >
Coronavirus, recently named “COVID-19” by the World Health Organization, presents like a Hollywood...
Read More >
Executive summary - This is the first time that the Supreme Court has had to decide an appeal relati...
Read More >
In Allison v. Eriksson, 479 Mass. 626 (Mass. 2018), a majority LLC member undertook a merger in viol...
Read More >
Mark your calendars! Oral argument has been scheduled in two cases that will address whether Title ...
Read More >